Table 9.

Common Effects for Novobiocin or Ciprofloxacin

Functional Group[i] Novobiocin Ciprofloxacin
Total no.of genes Increased % Decreased % Increased % Decreased %
Amino acid biosynthesis7057%2941%23%1623%
 Aromatic amino acid family1616%425%0%16%
 Aspartate family1816%739%16%844%
 Branched chain family100%550%0%0%
 Glutamate family9222%111%111%444%
 Histidine family90%9100%0%111%
 Serine family and pyruvate family8113%338%0%225%
Biosynthesis of cofactors,  prosthetic groups, and carriers5659%1629%0%24%
Cell envelope791215%1114%23%56%
Cellular processes5359%1223%12%59%
 Cell division17318%635%0%0%
 Chaperones60%233%0%233%
 Others3027%413%13%310%
Central intermediary metabolism3013%1240%0%723%
Energy metabolism109810%2119%46%1716%
Fatty acid and phospholipid  metabolism261142%519%28%28%
Hypothetical339476%2213%113%226%
Other categories9577%1415%11%55%
Purines, pyrimidines, nucleosides,  and nucleotides52612%510%12%510%
Regulatory functions6869%1116%23%812%
Replication, recombination, and  DNA repair841821%1417%1315%34%
Transcription26415%415%312%14%
 DNA-dependent RNA polymerase17318%318%212%16%
 Degradation of RNA9111%111%111%0%
Translation1431813%2316%1510%1712%
 Amino acyl tRNA synthetases34926%412%618%39%
 Ribosomal proteins synthesis and   modification5724%35%35%814%
 Others52713%1631%612%612%
Transport and binding proteins123108%3125%22%1915%
 Amino acids peptides and amines3838%1232%0%821%
 Other transport and binding   proteins8578%1911%22%1113%
Total135313210%28421%625%13410%

[i] As defined by Fleischmann et al. (1995).